Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

657.91 +11.04 (+1.71%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 782,812
Open 650.35
Bid (Size) 654.70 (120)
Ask (Size) 658.71 (80)
Prev. Close 646.87
Today's Range 640.99 - 658.21
52wk Range 476.49 - 834.42
Shares Outstanding 91,779,465
Dividend Yield 0.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%
Merck said Saturday its new pill — a possible rival to Regeneron and Amgen — lowered high cholesterol by almost 60%. 
Via Investor's Business Daily
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire

Performance

YTD
-8.0%
-8.0%
1 Month
+15.4%
+15.4%
3 Month
+20.5%
+20.5%
6 Month
+14.3%
+14.3%
1 Year
-20.6%
-20.6%

More News

Read More
Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Earnings Scheduled For October 28, 2025
Via Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Via Benzinga
Looking Into Regeneron Pharmaceuticals Inc's Recent Short Interest
Via Benzinga
The Shadow of Doubt: Why Investors Are 'Taking Fright' as Markets Brace for Reality
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
5 Revealing Analyst Questions From Regeneron’s Q3 Earnings Call
Via StockStory
Topics Earnings
Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts
Via Benzinga
Regeneron Announces Investor Conference Presentations
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
2 Beaten-Down Stocks That Could Be About to Rally
Via The Motley Fool
Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
REGN Q3 Deep Dive: Pipeline, Regulatory Progress, and Label Expansion Take Center Stage
Via StockStory
Regeneron (REGN) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?
Via Benzinga
Topics Economy
Why Are Regeneron (REGN) Shares Soaring Today
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks are gapping in today's session
Via Chartmill
Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
These S&P500 stocks that are showing activity before the opening bell on Tuesday.
Via Chartmill
Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness
Via Benzinga
Regeneron's Earnings Took A Big Tax Hit, And Still Pounded Forecasts
Via Investor's Business Daily
Regeneron Pharmaceuticals (NASDAQ:REGN) Q3 2025 Earnings Beat Estimates
Via Chartmill
Topics Earnings
Regeneron (NASDAQ:REGN) Surprises With Strong Q3
Via StockStory

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 657.91
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 11/07/25 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 60.38B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 60B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.